导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 25.48% | 176/1050 |
| 近一周 | -0.20% | 317/1104 |
| 近一月 | -2.31% | 408/1103 |
| 近一季 | -8.12% | 623/1092 |
| 近半年 | 13.62% | 222/1070 |
| 近一年 | 33.57% | 150/1018 |
| 近两年 | 124.68% | 145/926 |
| 近三年 | 72.51% | 154/834 |
| 成立以来 | 376.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.51% 168/1070 |
45.89% 242/1101 |
- - |
- - |
| 2025 | 54.21% 154/1065 |
5.37% 388/1014 |
2.50% 466/1038 |
37.96% 229/1050 |
3.51% 220/1065 |
| 2024 | -4.14% 677/1011 |
-5.87% 605/960 |
0.15% 298/983 |
9.12% 699/991 |
-6.81% 771/1011 |
| 2023 | -0.65% 109/952 |
9.47% 129/880 |
2.48% 82/895 |
-5.05% 310/915 |
-6.73% 651/952 |
| 2022 | -29.13% 599/867 |
-22.32% 654/773 |
9.70% 282/806 |
-16.75% 668/845 |
-0.10% 449/867 |
| 2021 | 15.15% 191/740 |
-1.51% 203/580 |
13.56% 272/659 |
-5.86% 382/704 |
9.36% 96/740 |
| 2020 | 66.06% 159/554 |
1.35% 127/419 |
31.01% 114/466 |
13.31% 173/517 |
10.38% 350/554 |
| 2019 | 79.55% 10/410 |
37.06% 105/1149 |
3.11% 108/1231 |
10.99% 98/390 |
14.48% 62/410 |
| 2018 | -31.46% 240/349 |
- - |
- - |
- - |
-15.10% 879/1080 |
| 2017 | 27.78% 51/285 |
- - |
- - |
- - |
- - |
| 2016 | -25.69% 137/205 |
- - |
- - |
- - |
- - |
| 2015 | 66.61% 10/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 富国高端制造行业股票A VS. 东吴新产业精选股票A(580008) |